Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surgical anastomosis

Nature Materials

Volumn 15, Issue 6, 2016, Pages 669-678

  Zhang, Boyang ^a,b   Montgomery, Miles ^a,b   Chamberlain, M Dean ^b   Ogawa, Shinichiro ^c   Korolj, Anastasia ^a,b   Pahnke, Aric ^a,b   Wells, Laura A ^b   Masse, Stephane ^d   Kim, Jihye ^a   Reis, Lewis ^b   Momen, Abdul ^e   Nunes, Sara S ^b,e,f   Wheeler, Aaron R ^a,b   Nanthakumar, Kumaraswamy ^d   Keller, Gordon ^c   Sefton, Michael V ^a,b   Radisic, Milica ^a,b,e,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f Richard Lewar Center of Excellence   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; ENDOTHELIAL CELLS; HISTOLOGY; SURGERY; TISSUE;

BIODEGRADABLE SCAFFOLD; BLOOD PERFUSION; CARDIAC TISSUES; HEPATIC TISSUE; MATERIAL CHOICE; PARENCHYMAL CELLS; THREE DIMENSIONAL MICROCHANNELS; VESSEL NETWORKS;

SCAFFOLDS (BIOLOGY);

BIOMATERIAL;

ANASTOMOSIS; ANIMAL; CARDIAC MUSCLE; CHEMISTRY; CYTOLOGY; DEVICES; FEMUR; HUMAN; LAB ON A CHIP; LEWIS RAT; LIVER; METABOLISM; MONOCYTE; POROSITY; PROCEDURES; RAT; TISSUE ENGINEERING; TISSUE SCAFFOLD; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ANASTOMOSIS, SURGICAL; ANIMALS; BIOCOMPATIBLE MATERIALS; FEMUR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAB-ON-A-CHIP DEVICES; LIVER; MONOCYTES; MYOCARDIUM; POROSITY; RATS; RATS, INBRED LEW; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84960154893     PISSN: 14761122     EISSN: 14764660     Source Type: Journal    
DOI: 10.1038/nmat4570     Document Type: Article

References (62)

1. Huh, D. et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662-1668 (2010).
2. Kim, H. J., Huh, D., Hamilton, G., Ingber, D. E. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12, 2165-2174 (2012).
3. Kolesky, D. B. et al. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv. Mater. 26, 3124-3130 (2014).
4. Zimmermann,W.-H. et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Med. 12, 452-458 (2006).
5. Nunes, S. S. et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nature Methods 10, 781-787 (2013).
6. Yang, X., Pabon, L., Murry, C. E. Engineering adolescence maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 114, 511-523 (2014).
7. Bian,W., Badie, N., Himel IV, H. D., Bursac, N. Robust T-tubulation and maturation of cardiomyocytes using tissue-engineered epicardial mimetics. Biomaterials 35, 3819-3828 (2014).
8. Takebe, T. et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481-484 (2013).
9. Thavandiran, N. et al. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc. Natl Acad. Sci. USA 110, E4698-E4707 (2013).
10. Legant,W. R. et al. Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues. Proc. Natl Acad. Sci. USA 106, 10097-10102 (2009).
11. Bian,W. Engineered skeletal muscle tissue networks with controllable architecture. Biomaterials 30, 1401-1412 (2009).
12. Kim, S., Lee, H., Chung, M., Jeon, N. L. Engineering of functional, perfusable 3D microvascular networks on a chip. Lab Chip 13, 1489-1500 (2013).
13. Zheng, Y. et al. In vitro microvessels for the study of angiogenesis and thrombosis. Proc. Natl Acad. Sci. USA 109, 9342-9347 (2012).
14. Zhang, B., Peticone, C., Murthy, S. K., Radisic, M. A standalone perfusion platform for drug testing and target validation in micro-vessel networks. Biomicrofluidics 7, 044125 (2013).
15. Atala, A., Kasper, F. K., Mikos, A. G. Engineering complex tissues. Sci. Transl. Med. 4, 160rv112 (2012).
16. Bae, H. et al. Building vascular networks. Sci. Transl. Med. 4, 160-123 (2012).
17. Ye, L., Zimmermann,W.-H., Garry, D. J., Zhang, J. Patching the heart cardiac repair from within and outside. Circ. Res. 113, 922-932 (2013).
18. Baranski, J. D. et al. Geometric control of vascular networks to enhance engineered tissue integration and function. Proc. Natl Acad. Sci. USA 110, 7586-7591 (2013).
19. Sekine, H. et al. In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nature Commun. 4, 1399 (2013).
20. Shandalov, Y. et al. An engineered muscle flap for reconstruction of large soft tissue defects. Proc. Natl Acad. Sci. USA 111, 6010-6015 (2014).
21. Miller, J. S. et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nature Mater. 11, 768-774 (2012).
22. Vollert, I. et al. In-vitro perfusion of engineered heart tissue through endothelialized channels. Tissue Eng. 20, 854-863 (2013).
23. Tang, M. D., Golden, A. P., Tien, J. Fabrication of collagen gels that contain patterned, micrometer-scale cavities. Adv. Mater. 16, 1345-1348 (2004).
24. Ye, X. et al. A biodegradable microvessel sca-old as a framework to enable vascular support of engineered tissues. Biomaterials 34, 10007-10015 (2013).
25. Bettinger, C. J. J. et al. Three-dimensional microfluidic tissue-engineering sca-olds using a flexible biodegradable polymer. Adv. Mater. 18, 165-169 (2006).
26. Bettinger, C. J. et al. Silk fibroin microfluidic devices. Adv. Mater. 19, 2847-2850 (2007).
27. Tran, R. T. et al. Synthesis and characterization of a biodegradable elastomer featuring a dual crosslinking mechanism. Soft Matter 6, 2449-2461 (2010).
28. Yang, J.,Webb, A. R., Ameer, G. A. Novel citric acid-based biodegradable elastomers for tissue engineering. Adv. Mater. 16, 511-516 (2004).
29. Spiller, K., Freytes, D., Vunjak-Novakovic, G. Macrophages modulate engineered human tissues for enhanced vascularization and healing. Ann. Biomed. Eng. 43, 616-627 (2014).
30. Kibbe, M. R. et al. Citric acid-based elastomers provide a biocompatible interface for vascular grafts. J. Biomed. Mater. Res. A 93A, 314-324 (2010).
31. Motlagh, D. et al. Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J. Biomed. Mater. Res. A 82A, 907-916 (2007).
32. Dendukuri, D., Pregibon, D. C., Collins, J., Hatton, T. A., Doyle, P. S. Continuous-flow lithography for high-throughput microparticle synthesis. Nature Mater. 5, 365-369 (2006).
33. Derby, B. Printing and prototyping of tissues and sca-olds. Science 338, 921-926 (2012).
34. Hoshi, R. A. Nanoporous biodegradable elastomers. Adv. Mater. 21, 188-192 (2009).
35. Nagueh, S. F. et al. Altered titin expression, myocardial sti-ness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 110, 155-162 (2004).
36. Weis, S. M. et al. Myocardial mechanics and collagen structure in the osteogenesis imperfecta murine (oim). Circ. Res. 87, 663-669 (2000).
37. Coirault, C. et al. Increased compliance in diaphragm muscle of the cardiomyopathic Syrian hamster. J. Appl. Physiol. 85, 1762-1769 (1998).
38. Omens, J. H. Stress and strain as regulators of myocardial growth. Prog. Biophys. Mol. Biol. 69, 559-572 (1998).
39. Yeh,W. C. et al. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med. Biol. 28, 467-474 (2002).
40. Merkel, T. C., Bondar, V. I., Nagai, K., Freeman, B. D., Pinnau, I. Gas sorption, di-usion, and permeation in poly(dimethylsiloxane). J. Polym. Sci. B 38, 415-434 (2000).
41. Toepke, M.W., Beebe, D. J. PDMS absorption of small molecules and consequences in microfluidic applications. Lab Chip 6, 1484-1486 (2006).
42. Gaillard, P. J. et al. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur. J. Pharm. Sci. 12, 215-222 (2001).
43. Yuan,W., Lv, Y., Zeng, M., Fu, B. M. Non-invasive measurement of solute permeability in cerebral microvessels of the rat. Microvasc. Res. 77, 166-173 (2009).
44. Adamson, R. H., Huxley, V. H., Curry, F. E. Single capillary permeability to proteins having similar size but di-erent charge. Am. J. Physiol. 254, H304-H312 (1988).
45. Woosley, R. L., Chen, Y., Freiman, J. P., Gillis, R. A. Mechanism of the cardiotoxic actions of terfenadine. JAMA 269, 1532-1536 (1993).
46. Ogawa, S. et al. Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development 140, 3285-3296 (2013).
47. Boudou, T. et al. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng. A 18, 910-919 (2012).
48. Radisic, M. et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on sca-olds. Proc. Natl Acad. Sci. USA 101, 18129-18134 (2004).
49. Tulloch, N. L. et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 109, 47-59 (2011).
50. Wu,W., Allen, R. A.,Wang, Y. Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery. Nature Med. 18, 1148-1153 (2012).
51. Bhatia, S., Balis, U., Yarmush, M., Toner, M. E-ect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J. 13, 1883-1900 (1999).
52. Mazza, E., Ehret, A. E. Mechanical biocompatibility of highly deformable biomedical materials. J. Mech. Behav. Biomed. Mater. 48, 100-124 (2015).
53. Engelmayr, G. C. et al. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nature Mater. 7, 1003-1010 (2008).
54. Nava, A., Mazza, E., Furrer, M., Villiger, P., Reinhart,W. In vivo mechanical characterization of human liver. Med. Image Anal. 12, 203-216 (2008).
55. Hoshi, R. A. et al. The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts. Biomaterials 34, 30-41 (2013).
56. Sefton, M. V., Gemmell, C. H., Gorbet, M. B. in Biomaterials Science 3rd edn (eds Ratner, B. D., Ho-man, A. S., Schoen, F. J., Lemons, J. E.) 758-760 (Academic, 2013).
57. Zhang, B., Green, J. V., Murthy, S. K., Radisic, M. Label-free enrichment of functional cardiomyocytes using microfluidic deterministic lateral flow displacement. PLoS ONE 7, e37619 (2012).
58. Ogawa, M. et al. Directed di-erentiation of cholangiocytes from human pluripotent stem cells. Nature Biotech. 33, 853-861 (2015).
59. Berry, M., Friend, D. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J. Cell Biol. 43, 506-520 (1969).
60. Kennedy, M., D'Souza, S. L., Lynch-Kattman, M., Schwantz, S., Keller, G. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell di-erentiation cultures. Blood 109, 2679-2687 (2007).
61. Lian, X. et al. Directed cardiomyocyte di-erentiation from human pluripotent stem cells by modulatingWnt/-catenin signaling under fully defined conditions. Nature Protocols 8, 162-175 (2013).
62. Zeebregts, C., Heijmen, R., Van Den Dungen, J., Van Schilfgaarde, R. Non-methods of vascular anastomosis. Br. J. Surg. 90, 261-271 (2003).